Clinical pharmacological studies on centpropazine--a new antidepressant compound.
dc.contributor.author | Gupta, P P | en_US |
dc.contributor.author | Asthana, O P | en_US |
dc.contributor.author | Tangri, A N | en_US |
dc.contributor.author | Dhawan, B N | en_US |
dc.date.accessioned | 1989-10-01 | en_US |
dc.date.accessioned | 2009-05-27T07:17:47Z | |
dc.date.available | 1989-10-01 | en_US |
dc.date.available | 2009-05-27T07:17:47Z | |
dc.date.issued | 1989-10-01 | en_US |
dc.description.abstract | Single oral doses of 10 to 160 mg centpropazine, a new antidepressant (synthesized by CDRI, Lucknow, India) were administered to groups of 4-5 male volunteers, each dose being interspersed with placebo in a double blind, non-crossover study by random distribution. The drug was well tolerated. Drowsiness, heaviness, weakness and/or headache were reported only at doses of 120 mg and above. No adverse effect was noted in various laboratory tests, ECG or vital parameters. In a multiple dose study, volunteers received 40 or 80 mg centpropazine daily for 4 wk. Mild restlessness and insomnia were observed in some subjects receiving 80 mg dose. In this study also no effect was observed in various laboratory tests, ECG or vital parameters. | en_US |
dc.identifier.citation | Gupta PP, Asthana OP, Tangri AN, Dhawan BN. Clinical pharmacological studies on centpropazine--a new antidepressant compound. Indian Journal of Medical Research. 1989 Oct; 90(): 360-2 | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/20119 | |
dc.language.iso | eng | en_US |
dc.source.uri | https://icmr.nic.in/ijmr/ijmr.htm | en_US |
dc.subject.mesh | Adolescent | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Aged | en_US |
dc.subject.mesh | Antidepressive Agents --adverse effects | en_US |
dc.subject.mesh | Dose-Response Relationship, Drug | en_US |
dc.subject.mesh | Double-Blind Method | en_US |
dc.subject.mesh | Drug Evaluation | en_US |
dc.subject.mesh | Drug Tolerance | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Middle Aged | en_US |
dc.subject.mesh | Piperazines | en_US |
dc.subject.mesh | Random Allocation | en_US |
dc.title | Clinical pharmacological studies on centpropazine--a new antidepressant compound. | en_US |
dc.type | Clinical Trial | en_US |
dc.type | Journal Article | en_US |
dc.type | Randomized Controlled Trial | en_US |
Files
License bundle
1 - 1 of 1